SLC7A11 and breast carcinoma: Using the example of MDA-MB-231 breast cancer cells, it was shown that 18-β-glycyrrhetinic acid (GA) suppressed the expression of SLC7A11 of the xc- system, reduced the level of GSH, inhibited GPX activity and induced ferroptosis [145].